Welcure Drugs and Pharmaceuticals Limited (BOM:524661)
India
· Delayed Price · Currency is INR 0.280
-0.010 (-3.45%)
At close: Mar 10, 2026
BOM:524661 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 1.28 | 0.22 | 0.01 | 0.66 | 0.47 | Upgrade
|
| Cash & Short-Term Investments | 1.24 | 1.28 | 0.22 | 0.01 | 0.66 | 0.47 | Upgrade
|
| Cash Growth | -45.55% | 493.98% | 1700.00% | -98.18% | 39.09% | 795.43% | Upgrade
|
| Accounts Receivable | - | 189.5 | - | - | - | - | Upgrade
|
| Receivables | - | 189.5 | - | - | - | - | Upgrade
|
| Inventory | - | 1,435 | - | - | - | - | Upgrade
|
| Other Current Assets | - | 195.39 | 0.1 | 0.05 | - | - | Upgrade
|
| Total Current Assets | - | 1,821 | 0.32 | 0.06 | 0.66 | 0.47 | Upgrade
|
| Property, Plant & Equipment | - | 0.3 | 0.21 | 0.57 | - | - | Upgrade
|
| Long-Term Investments | - | - | - | 1.65 | - | - | Upgrade
|
| Other Long-Term Assets | - | 0.77 | 0.31 | 0.31 | 0.31 | 0.26 | Upgrade
|
| Total Assets | - | 2,670 | 13.71 | 15.29 | 0.97 | 0.73 | Upgrade
|
| Accounts Payable | - | 28.98 | - | - | - | - | Upgrade
|
| Accrued Expenses | - | 0.61 | 0.11 | 0.14 | 0.04 | 0.04 | Upgrade
|
| Current Income Taxes Payable | - | 6.1 | - | - | - | - | Upgrade
|
| Other Current Liabilities | - | 377 | 0.2 | - | - | 0 | Upgrade
|
| Total Current Liabilities | - | 412.69 | 0.31 | 0.14 | 0.04 | 0.04 | Upgrade
|
| Long-Term Debt | - | 1,232 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | -0 | 0 | - | - | Upgrade
|
| Total Liabilities | - | 1,645 | 0.31 | 0.14 | 0.04 | 0.04 | Upgrade
|
| Common Stock | - | 1,124 | 134.39 | 134.39 | 121.19 | 121.19 | Upgrade
|
| Retained Earnings | - | -99.29 | -120.99 | -119.24 | -120.26 | -120.49 | Upgrade
|
| Comprehensive Income & Other | - | - | - | -0 | - | - | Upgrade
|
| Shareholders' Equity | 1,343 | 1,025 | 13.41 | 15.15 | 0.93 | 0.69 | Upgrade
|
| Total Liabilities & Equity | - | 2,670 | 13.71 | 15.29 | 0.97 | 0.73 | Upgrade
|
| Total Debt | 1,232 | 1,232 | - | - | - | - | Upgrade
|
| Net Cash (Debt) | -1,231 | -1,231 | 0.22 | 0.01 | 0.66 | 0.47 | Upgrade
|
| Net Cash Growth | - | - | 1700.00% | -98.18% | 39.09% | 795.43% | Upgrade
|
| Net Cash Per Share | -0.72 | -1.43 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Filing Date Shares Outstanding | 82.05 | 1,238 | 148.63 | 148.63 | 148.63 | 147.41 | Upgrade
|
| Total Common Shares Outstanding | 82.05 | 1,238 | 148.63 | 148.63 | 148.63 | 147.41 | Upgrade
|
| Working Capital | - | 1,409 | 0.01 | -0.08 | 0.62 | 0.44 | Upgrade
|
| Book Value Per Share | 1.09 | 0.83 | 0.09 | 0.10 | 0.01 | 0.00 | Upgrade
|
| Tangible Book Value | 1,343 | 1,025 | 13.41 | 15.15 | 0.93 | 0.69 | Upgrade
|
| Tangible Book Value Per Share | 1.09 | 0.83 | 0.09 | 0.10 | 0.01 | 0.00 | Upgrade
|
| Machinery | - | 0.77 | 0.6 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.